[Medical therapy of thrombosis].
D000925:Anticoagulants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001241:Aspirin / Q000494:pharmacology; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D010653:Phenylbutazone / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects; D013442:Sulfinpyrazone / Q000494:pharmacology; D013927:Thrombosis / Q000188:drug therapy* / Q000517:prevention & control
D000925:Anticoagulants; D000959:Antihypertensive Agents; D005343:Fibrinolytic Agents; D000960:Hypolipidemic Agents; D010653:Phenylbutazone; D001241:Aspirin; D013442:Sulfinpyrazone
La terapia medica della malattia trombotica.